These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1695784)

  • 1. Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia.
    Caine M
    Urol Clin North Am; 1990 Aug; 17(3):641-9. PubMed ID: 1695784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-adrenergic mechanisms in dynamics of benign prostatic hypertrophy.
    Caine M
    Urology; 1988 Dec; 32(6 Suppl):16-20. PubMed ID: 2462300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.
    Lowe FC
    Clin Ther; 2004 Nov; 26(11):1701-13. PubMed ID: 15639685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of alpha blockers in BPH.
    Jardin A
    Prog Clin Biol Res; 1994; 386():279-83. PubMed ID: 7528395
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current drug therapy of benign prostatic hyperplasia].
    Schmidbauer CP; Madersbacher S
    Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New use for alpha blockers: benign prostatic hyperplasia.
    Hill SJ; Lawrence SL; Lepor H
    Am Fam Physician; 1994 Jun; 49(8):1885-8, 1893-4. PubMed ID: 7515555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological treatment of benign prostatic hyperplasia].
    Hansen J; Hald T
    Ugeskr Laeger; 1993 Dec; 155(50):4058-64. PubMed ID: 7505965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of long-acting selective alpha-1 blockers in the treatment of benign prostatic hyperplasia.
    Lepor H
    Urol Clin North Am; 1990 Aug; 17(3):651-9. PubMed ID: 1695785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryologic development of the prostate. Insights into the etiology and treatment of benign prostatic hyperplasia.
    Shapiro E
    Urol Clin North Am; 1990 Aug; 17(3):487-93. PubMed ID: 1695777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha adrenergic antagonists for the treatment of symptomatic BPH.
    Lepor H
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):151-5. PubMed ID: 2469658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BPH alpha blocker therapy.
    Vela-Navarrete R
    J Urol (Paris); 1995; 101(1):26-8. PubMed ID: 7545722
    [No Abstract]   [Full Text] [Related]  

  • 14. [Uroselectivity of alpha-1 antagonism in the treatment of benign prostatic hypertrophy: on the pharmacologic concept of the clinical approach].
    Jolliet P; Bourin M
    Therapie; 1998; 53(1):61-6. PubMed ID: 9773101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical management of benign prostatic hyperplasia: a review.
    Magoha GA
    East Afr Med J; 1996 Jul; 73(7):453-6. PubMed ID: 8918007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-blockers in the treatment of benign prostatic hypertrophy: physiological basis and review of the problem.
    Bouffioux CR; Penders L
    Eur Urol; 1984; 10(5):306-10. PubMed ID: 6083868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The place of pharmacologic treatment in benign prostatic hyperplasia.
    Caine M
    Semin Urol; 1985 Nov; 3(4):311-6. PubMed ID: 2441447
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha blockade for the treatment of benign prostatic hyperplasia.
    Lepor H
    Urol Clin North Am; 1995 May; 22(2):375-86. PubMed ID: 7539182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
    Tahmatzopoulos A; Kyprianou N
    Prostate; 2004 Apr; 59(1):91-100. PubMed ID: 14991869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
    Naslund MJ; Miner M
    Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.